SARS-CoV-2 spike protein mutation variants: Recent advances in theragnostic and vaccines development
Background: COVID-19, caused by SARS-CoV-2 and linked to over 6.5 million deaths, has severely disrupted global healthcare systems with long-lasting impacts. Developing effective vaccines and treatments requires a deep understanding of host-virus interactions. Designing new tactics to reduce the con...
Saved in:
Main Authors: | Jutishna Bora, Akash Deep, Archana Dashmana, Smita Lata, Shailendra Thapliyal, Nayan Talukdar, Ravi K. Deshwal, Sarvesh Rustagi, Sumira Malik |
---|---|
Format: | Article |
Language: | English |
Published: |
Zagazig University, Faculty of Medicine
2025-08-01
|
Series: | Microbes and Infectious Diseases |
Subjects: | |
Online Access: | https://mid.journals.ekb.eg/article_430671_04beb5cca4aa0f9ac14856d83892515e.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Influence of SARS-CoV-2 variants’ spike glycoprotein and RNA-dependent RNA polymerase (nsp12) mutations on remdesivir docking residues
by: Ali A. Dawood
Published: (2022-07-01) -
Additional insights on SARS-CoV-2 spike protein variants and red blood cells biology
by: Francesco Dima, et al.
Published: (2025-06-01) -
Multi-epitope vaccine against SARS-CoV-2 targeting the spike RBD: an immunoinformatics approach
by: Yasamin Pahlavan, et al.
Published: (2024-12-01) -
Clinical features of post-COVID period. Results of an International Register "Dynamics Analysis of Comorbidities in SARS-CoV-2 Survivors (ACTIV SARS-CoV-2)" (12-month follow-up)
by: G. P. Arutyunov, et al.
Published: (2023-02-01) -
Antibodies to the receptor-binding domain of the SARS-Cov-2 spike protein: association with age, pneumonia, duration of the period after COVID-19
by: E. A. Kolosova, et al.
Published: (2022-04-01)